darolutamide
bayer
['darolutamide', 'crpc', 'aramis']
darol: real-world study of darolutamide in nmcrpc pts (n=300) any grade darolutamide-related teae: 24% (most common: fatigue 8%) gr 3-4 aes: 4% safety profile similar to that observed in aramis psa50: 76%, psa90: 54% (other efficacy endpoints pending) #asco23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @MCG_Urology and @AUB_Lebanon 🇱🇧